REMS-Certified Provider

Spravato (Esketamine)
Nasal Spray in Rockville, MD

Spravato is an FDA-approved esketamine nasal spray for adults with treatment-resistant depression and major depressive disorder with suicidal thoughts. Administered in-office under medical supervision. Covered by most major insurance — including Medicaid and Medicare.


Led by Johns Hopkins–trained psychiatrist

FDA-approved nasal spray — not an IV infusion

Can begin working within hours, not weeks

Esketamine Nasal Spray (Spravato®)

FDA-Approved Nasal Spray

Not an IV. Not an injection. FDA-approved.

Fast-Acting Relief

Some patients feel a shift the same day

Covered by Insurance

Including Medicaid & Medicare

Understanding Spravato

What Is Spravato (Esketamine)?

Spravato is the brand name for esketamine — an FDA-approved nasal spray used to treat treatment-resistant depression (TRD) and major depressive disorder (MDD) with active suicidal ideation.

Unlike traditional antidepressants, which take 4–6 weeks to work and target serotonin, Spravato works on the glutamate system — the brain’s most abundant neurotransmitter. It’s thought to help the brain rapidly form new neural connections, which is why some patients notice improvement within hours of their first dose.

It’s a nasal spray, not an IV drip or injection. It’s administered by our clinical staff at our Rockville office under medical supervision. After each dose, you stay for a 2-hour monitoring period. Then someone drives you home.

Conditions Treated

What Can Spravato (Esketamine) Treat?

Spravato has two FDA-approved uses, and growing clinical evidence for additional conditions.

Treatment-Resistant Depression (TRD)

This is Spravato’s primary FDA-approved indication. If you’ve tried two or more antidepressants and they haven’t worked — or stopped working — you likely meet the criteria. Spravato is taken alongside an oral antidepressant, not instead of one.

Major Depression with Suicidal Ideation

Spravato is one of very few treatments FDA-approved specifically for adults with MDD who are actively experiencing suicidal thoughts. Its rapid onset — often within hours — is what makes it uniquely valuable for this indication, where waiting weeks for an antidepressant to work isn’t an option.

Spravato for Anxiety

Spravato isn’t FDA-approved specifically for anxiety, but many patients with anxious depression — depression with significant anxiety symptoms — see improvement in both. The glutamate pathway it targets plays a role in anxiety regulation as well. This is something we evaluate on a case-by-case basis.

Spravato for PTSD

Research into esketamine for PTSD is still developing, but early results are promising — particularly for patients whose PTSD overlaps with treatment-resistant depression. We consider Spravato for these patients when traditional approaches haven’t been enough.

The Experience

What Does Spravato Treatment Feel Like?

Here’s what to actually expect during and after a Spravato session at our Rockville office.

During the Spray

5 Minutes

Our staff administers the nasal spray — two or three devices depending on your dose. It has a mild bitter taste. Some people feel a slight burning in the nose. The whole process takes about 5 minutes.

Monitoring Period

2 Hours

You stay in our office while the medication takes effect. Common feelings: mild dissociation, light-headedness, drowsiness, or a sense of “floating.” Some patients describe it as a dreamlike state. It typically peaks around 40 minutes and fades by the 2-hour mark.

After Treatment

Rest of the Day

Someone drives you home. Don’t drive, operate machinery, or make important decisions until the next morning. Most patients feel normal by the next day. Some notice a genuine improvement in mood surprisingly quickly.

Spravato Treatment Schedule

Weeks 1–4 (Induction): Two sessions per week at our office. This is when the medication builds its initial therapeutic effect.

Weeks 5–8 (Transition): Once per week. Your provider assesses response and adjusts dosing.

Week 9+ (Maintenance): Once every week or every two weeks, based on how you’re doing. Some patients eventually taper to once per month.

Comparisons

Spravato vs Ketamine: What’s the Difference?

This is the most common question we hear. Spravato and ketamine are related — but they’re not the same treatment. Here’s how they compare.

Spravato (Esketamine)

IV Ketamine Infusion

TMS Therapy

What It Is

IV drip of racemic ketamine

Magnetic pulses to the brain

FDA Status

Not FDA-approved for depression (off-label use)

FDA-approved for depression & OCD

Administration

IV infusion in a clinic, 40–60 min

Device placed on head, 20–30 min

Insurance

Rarely covered — typically out-of-pocket

Covered by most major plans

Speed of Effect

Hours to days

2–3 weeks typically

Schedule

6 infusions over 2–3 weeks + boosters

5 days/week for 4–6 weeks

Monitoring

Observation required during infusion

None — drive yourself home

Typical Cost

$400–$800 per infusion (self-pay)

Copay only with insurance

The short version: Spravato is the only FDA-approved form of ketamine-based treatment for depression.
It’s a nasal spray rather than an IV, and it’s covered by insurance.
That combination — clinical approval, nasal delivery, and insurance coverage — is why it’s become the standard at practices like ours.

We accept major insurance providers

including Medicare & Medicaid

Aetna Blue Cross Blue Shield Cigna Tricare United Healthcare John Hopkins Medicaid Medicare

Safety

Spravato Side Effects

Most side effects are temporary and happen during or shortly after the 2-hour monitoring period. Here’s the honest breakdown.

Common Side Effects

  • Dissociation (feeling detached or “floaty”) — most common, fades within 1–2 hours
  • Dizziness or light-headedness
  • Nausea — more common in the first few sessions
  • Drowsiness or sedation
  • Increased blood pressure (temporary — we monitor it)
  • Headache
  • Nasal discomfort or a bitter taste

Pricing & Insurance

How Much Does Spravato Cost?

Insurance coverage is the biggest factor. Here’s what to expect.

Spravato Cost with Insurance

$0 – $35

per session (with copay card + insurance)

Most major insurance plans cover Spravato once treatment-resistant depression is documented. The manufacturer also offers a Spravato savings card that can reduce your copay to as low as $10 per session. We handle prior authorization for you.

Aetna Blue Cross Blue Shield Cigna Tricare United Healthcare Medicare Medicaid Johns Hopkins EHP

Spravato Cost Without Insurance

$590 – $890

per session (varies by dose — 56mg vs 84mg)

Without insurance, Spravato is expensive. This is one of its key advantages over IV ketamine, though — because insurance actually covers it. Not sure about your coverage? Call us and we’ll check before your first visit.

Does Medicaid or Medicare Cover Spravato?

Yes — both Medicaid and Medicare cover Spravato in most cases. Medicare Part B covers it as an in-office administered medication. Medicaid coverage varies by state but is available in Maryland. We verify coverage and handle all paperwork on your behalf.

Esketamine Nasal Spray (Spravato®)

Meet Your Doctor

Dr. Amir Etesam, MD

Psychiatrist & Medical Director

Dr. Amir Etesam, MD, is a Johns Hopkins–trained, Board-Certified, psychiatrist and the founder of Bright Horizons Psychiatry in North Bethesda, Maryland. He is a distinguished member of Alpha Omega Alpha (AOA), the nation’s most respected medical honor society, recognizing excellence in scholarship and integrity in medicine.

Dr. Etesam’s clinical work is exclusively focused on patients with treatment-resistant major depressive disorder (TRD)—those who have not improved despite multiple trials of medication and therapy. His practice centers on advanced neuromodulation therapies, including Transcranial Magnetic Stimulation (TMS) and Intranasal Esketamine (Spravato®), provided in a private, state-of-the-art setting designed for comfort and healing.

He no longer accepts new patients for other psychiatric conditions such as anxiety, ADHD, bipolar disorder, or OCD.

For patients seeking care for other psychiatric conditions—such as anxiety, ADHD, bipolar disorder, and general mood or behavioral concerns—a highly trained team of psychiatric nurse practitioners works side-by-side with, and under the close supervision of Dr. Etesam. This collaborative model ensures that every patient receives the same standard of thoughtful, evidence-based care that defines Bright Horizons Psychiatry.

Common Questions

Frequently Asked Questions
About Spravato

No. Because of esketamine’s dissociative effects and abuse potential, the FDA requires Spravato to be administered only in a REMS-certified healthcare setting by trained clinical staff. You receive the nasal spray in our office and stay for 2 hours of monitoring. You cannot take it home, fill a prescription at a pharmacy, or use it outside of a certified clinic.

Yes — most major insurance plans cover Spravato, including Aetna, BCBS, Cigna, United Healthcare, Carefirst, Medicare, and Medicaid. Prior authorization is typically required, which means your insurer needs documentation that you have treatment-resistant depression. We handle the entire prior auth process on your behalf.

Related, but not the same. Ketamine contains two mirror-image molecules: S-ketamine and R-ketamine. Spravato contains only the S-ketamine (esketamine), which is the more potent of the two for mood regulation. The key practical differences: Spravato is FDA-approved, administered as a nasal spray, and covered by insurance. IV ketamine is off-label, administered as an infusion, and almost never covered by insurance.

Some patients notice a difference within hours of their first session. For others, it takes a few treatments. Clinical trials showed significant improvement as early as 24 hours after the first dose for some patients. The full treatment protocol involves an induction phase (twice per week for 4 weeks) before assessing full response.

No — weight gain is not a reported side effect of Spravato. This is a significant advantage for patients who have experienced weight gain from traditional antidepressants like SSRIs, SNRIs, or mood stabilizers. If medication-related weight gain is a concern for you, this is worth discussing at your consultation.

Esketamine is classified as a Schedule III controlled substance, meaning it does have potential for misuse. That’s exactly why it can only be administered in a REMS-certified healthcare setting under supervision — never at home. In clinical practice, when used as prescribed in a monitored environment, the risk of addiction is low.

Yes — Medicaid covers Spravato in Maryland. Medicare Part B also covers it as a physician-administered treatment. We verify your specific coverage and handle prior authorization before your first session. If you’re unsure about your plan, just call us at (301) 689-1500 and we’ll check for you.

Esketamine is mostly cleared from the body within 24 hours. The dissociative effects peak around 40 minutes after administration and typically resolve within 2 hours. You should not drive or operate machinery until the next day, but most patients feel completely normal by the following morning.

Ready to Get Started?

Find out if Spravato
is right for you.

Free 30-minute consultation. We’ll tell you honestly whether Spravato makes sense for your situation — or if another treatment would be a better fit.